Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Imperagen has raised $6.7M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Imperagen's investors include IQ Capital, Northern Gritstone, PXN Ventures.
Imperagen is headquartered in Manchester, United Kingdom.
Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Imperagen is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Imperagen — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/imperagen. Accessed July 20, 2026.
VCBacked. (2026). Imperagen — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/imperagen
{{cite web |title=Imperagen — Funding & Investors |url=https://www.vcbacked.co/company/imperagen |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated